Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Post by valueplaysonlyon Sep 30, 2013 7:47pm

188 Views

Post# 21779695

Dart doubled down on mediocrity!!!!!!!!!

Pretty soon his people will be contacting yours truly VPO for financial advice and how to help them in stock picking. Ken , I'm semi -retired now to be honest but in case your people are THINKING of contacting me, my management fee is 20 % plus 5 million a year.

I dont do the Caymans any more . I am a hobby gardener and love my estate too much to leave it for number crunching . That I can do from my home office.

Bullboard Posts

High Tide adds two stores to undervalued cannabis retail network